Noemi Rotllan earned her Ph.D. degree in 2003 from Barcelona University. She did a postdoctoral trainee at New York University and Yale University, where she was an Associate Research Scientist. In 2019, she got the prestigious Ramon y Cajal fellowship and she moved back to Barcelona in order to start her own laboratory. Her research interests are focused mainly on the role of new microRNAs in hiperhomocysteinemia related atherosclerosis and to use an innovative therapeutic approach for targeting miRNAs in vivo using pHLIP or rHDL. She has published more than 80 research articles in SCI(E) journals.